We’re an established health economics and outcomes consultancy that anticipates your needs and exceeds your expectations

Recent activities

Health economic modelling: a guide for pharmaceutical and medical device companies
The purpose of health economic evaluation is to support decision makers in allocating limited healthcare resources to achieve the best possible...
Evidence generation and communication in drug development
Clinical evidence generation: clinical trials Health researchers continually discover new evidence that deepens our understanding of disease...
Evidence synthesis for healthcare decision-making
What is evidence synthesis? As the pharmaceutical market rapidly evolves to keep pace with patient needs and emerging research, healthcare decision...
Market access for immuno-oncology (I-O) drugs in the UK
The rapid development of immuno-oncology (I-O) therapies has transformed the cancer treatment landscape, but health technology assessment (HTA)...

Economic value of insertable cardiac monitors in unexplained syncope in the United States

We’re excited to have co-authored a publication in the BMJ Open Heart Journal assessing the cost-effectiveness of a novel diagnostic device. 

Assessing the quality and coherence of network meta-analyses of biologics in plaque psoriasis: what does all this evidence synthesis tell us?

We’re thrilled to have co-authored a publication in Dermatology and Therapy to appraise and synthesise the published evidence on biological therapies for plaque psoriasis. 

Outcomes-based contracts for medicines in Europe

Are you interested in outcomes-based contracts? Click below to learn more about our work on European healthcare systems and challenges in planning and implementation.

Vagus nerve stimulation for drug-resistant epilepsy patients in England

We’re excited to have published an economic evaluation of this innovative device. 

Our work in numbers

43

total clients

28

billion USD – average client turnover

67

% of work conducted with global HQ

Our story

We discover and drive innovative solutions to bring lifesaving treatments to patients around the world.

We work with our clients as a trusted partner and critical friend. Hence our name, Symmetron, from the Greek sym (together) and metron (calculate).

Since 2008, we have been growing steadily in size and capability into a highly-respected source of research in health economics and health outcomes.

Find out more about our successes 

We discover and drive innovative solutions to bring lifesaving treatments to patients around the world.

We work with our clients as a trusted partner and critical friend. Hence our name, Symmetron, from the Greek sym (together) and metron (calculate).

Since 2008, we have been growing steadily in size and capability to a highly-respected source of research in health economics and health outcomes.

Find out more about our successes